Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report)’s stock price rose 0.6% during trading on Tuesday . The company traded as high as $10.00 and last traded at $9.76. Approximately 2,698 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 37,647 shares. The stock had previously closed at $9.70.
Invizyne Technologies Price Performance
The stock’s 50-day moving average is $10.38 and its 200 day moving average is $12.72.
Institutional Investors Weigh In On Invizyne Technologies
Hedge funds and other institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets acquired a new stake in shares of Invizyne Technologies during the 4th quarter valued at approximately $35,000. Geode Capital Management LLC acquired a new stake in shares of Invizyne Technologies during the 4th quarter valued at approximately $277,000. Finally, Citadel Advisors LLC acquired a new stake in shares of Invizyne Technologies during the 4th quarter valued at approximately $456,000.
About Invizyne Technologies
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
Further Reading
- Five stocks we like better than Invizyne Technologies
- Golden Cross Stocks: Pattern, Examples and Charts
- Buffett’s Cash Hoard Signals Market Caution, Value Plays Emerge
- Insider Trading – What You Need to Know
- DLocal Stock Soars 43% After Earnings Beat and Raised Guidance
- What Are Dividends? Buy the Best Dividend Stocks
- Can AI Defense Contracts Push Palantir Shares Higher?
Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.